RMC No. 108-2025: Updated VAT-Exempt Drug List for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, Tuberculosis, and High Cholesterol
RMC No. 108-2025 updates the FDA-endorsed VAT-exempt drug list for key illnesses, affecting pharmacies, healthcare firms, and corporate tax teams. Businesses selling, importing, prescribing, purchasing, reimbursing, or accounting for qualified medicines must immediately validate their product master files, invoices, VAT treatment, and reimbursement rules against the updated VAT-exempt drug list endorsed by the Food and […]